The global market for Gene Therapy Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gene Therapy Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Gene Therapy Products by region & country, by Type, and by Application.

The Gene Therapy Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy Products.

Market Segmentation

Scope of Gene Therapy Products - Market Report

Report Metric	Details
Report Name	Gene Therapy Products - Market
CAGR	5%
Segment by Type:	Ex vivo In Vivo
Segment by Application	Cancer Monogenic Infectious disease Cardiovascular disease Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gene Therapy Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Gene Therapy Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Gene Therapy Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Gene Therapy Products - Market report?

Ans: The main players in the Gene Therapy Products - Market are Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene

What are the Application segmentation covered in the Gene Therapy Products - Market report?

Ans: The Applications covered in the Gene Therapy Products - Market report are Cancer, Monogenic, Infectious disease, Cardiovascular disease, Other

What are the Type segmentation covered in the Gene Therapy Products - Market report?

Ans: The Types covered in the Gene Therapy Products - Market report are Ex vivo, In Vivo

1 Market Overview

1.1 Gene Therapy Products Product Introduction

1.2 Global Gene Therapy Products Market Size Forecast

1.2.1 Global Gene Therapy Products Sales Value (2019-2030)

1.2.2 Global Gene Therapy Products Sales Volume (2019-2030)

1.2.3 Global Gene Therapy Products Sales Price (2019-2030)

1.3 Gene Therapy Products Market Trends & Drivers

1.3.1 Gene Therapy Products Industry Trends

1.3.2 Gene Therapy Products Market Drivers & Opportunity

1.3.3 Gene Therapy Products Market Challenges

1.3.4 Gene Therapy Products Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Gene Therapy Products Players Revenue Ranking (2023)

2.2 Global Gene Therapy Products Revenue by Company (2019-2024)

2.3 Global Gene Therapy Products Players Sales Volume Ranking (2023)

2.4 Global Gene Therapy Products Sales Volume by Company Players (2019-2024)

2.5 Global Gene Therapy Products Average Price by Company (2019-2024)

2.6 Key Manufacturers Gene Therapy Products Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Gene Therapy Products Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Gene Therapy Products

2.9 Gene Therapy Products Market Competitive Analysis

2.9.1 Gene Therapy Products Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Gene Therapy Products Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Products as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Ex vivo

3.1.2 In Vivo

3.2 Global Gene Therapy Products Sales Value by Type

3.2.1 Global Gene Therapy Products Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Gene Therapy Products Sales Value, by Type (2019-2030)

3.2.3 Global Gene Therapy Products Sales Value, by Type (%) (2019-2030)

3.3 Global Gene Therapy Products Sales Volume by Type

3.3.1 Global Gene Therapy Products Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Gene Therapy Products Sales Volume, by Type (2019-2030)

3.3.3 Global Gene Therapy Products Sales Volume, by Type (%) (2019-2030)

3.4 Global Gene Therapy Products Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cancer

4.1.2 Monogenic

4.1.3 Infectious disease

4.1.4 Cardiovascular disease

4.1.5 Other

4.2 Global Gene Therapy Products Sales Value by Application

4.2.1 Global Gene Therapy Products Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Gene Therapy Products Sales Value, by Application (2019-2030)

4.2.3 Global Gene Therapy Products Sales Value, by Application (%) (2019-2030)

4.3 Global Gene Therapy Products Sales Volume by Application

4.3.1 Global Gene Therapy Products Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Gene Therapy Products Sales Volume, by Application (2019-2030)

4.3.3 Global Gene Therapy Products Sales Volume, by Application (%) (2019-2030)

4.4 Global Gene Therapy Products Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Gene Therapy Products Sales Value by Region

5.1.1 Global Gene Therapy Products Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Gene Therapy Products Sales Value by Region (2019-2024)

5.1.3 Global Gene Therapy Products Sales Value by Region (2025-2030)

5.1.4 Global Gene Therapy Products Sales Value by Region (%), (2019-2030)

5.2 Global Gene Therapy Products Sales Volume by Region

5.2.1 Global Gene Therapy Products Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Gene Therapy Products Sales Volume by Region (2019-2024)

5.2.3 Global Gene Therapy Products Sales Volume by Region (2025-2030)

5.2.4 Global Gene Therapy Products Sales Volume by Region (%), (2019-2030)

5.3 Global Gene Therapy Products Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Gene Therapy Products Sales Value, 2019-2030

5.4.2 North America Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Gene Therapy Products Sales Value, 2019-2030

5.5.2 Europe Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Gene Therapy Products Sales Value, 2019-2030

5.6.2 Asia Pacific Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Gene Therapy Products Sales Value, 2019-2030

5.7.2 South America Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Gene Therapy Products Sales Value, 2019-2030

5.8.2 Middle East & Africa Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Gene Therapy Products Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Gene Therapy Products Sales Value

6.2.1 Key Countries/Regions Gene Therapy Products Sales Value, 2019-2030

6.2.2 Key Countries/Regions Gene Therapy Products Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Gene Therapy Products Sales Value, 2019-2030

6.3.2 United States Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Gene Therapy Products Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Gene Therapy Products Sales Value, 2019-2030

6.4.2 Europe Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Gene Therapy Products Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Gene Therapy Products Sales Value, 2019-2030

6.5.2 China Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

6.5.3 China Gene Therapy Products Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Gene Therapy Products Sales Value, 2019-2030

6.6.2 Japan Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Gene Therapy Products Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Gene Therapy Products Sales Value, 2019-2030

6.7.2 South Korea Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Gene Therapy Products Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Gene Therapy Products Sales Value, 2019-2030

6.8.2 Southeast Asia Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Gene Therapy Products Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Gene Therapy Products Sales Value, 2019-2030

6.9.2 India Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

6.9.3 India Gene Therapy Products Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bluebird Bio

7.1.1 Bluebird Bio Company Information

7.1.2 Bluebird Bio Introduction and Business Overview

7.1.3 Bluebird Bio Gene Therapy Products Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Bluebird Bio Gene Therapy Products Product Offerings

7.1.5 Bluebird Bio Recent Development

7.2 Sangamo

7.2.1 Sangamo Company Information

7.2.2 Sangamo Introduction and Business Overview

7.2.3 Sangamo Gene Therapy Products Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sangamo Gene Therapy Products Product Offerings

7.2.5 Sangamo Recent Development

7.3 Spark Therapeutics

7.3.1 Spark Therapeutics Company Information

7.3.2 Spark Therapeutics Introduction and Business Overview

7.3.3 Spark Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Spark Therapeutics Gene Therapy Products Product Offerings

7.3.5 Spark Therapeutics Recent Development

7.4 Dimension Therapeutics

7.4.1 Dimension Therapeutics Company Information

7.4.2 Dimension Therapeutics Introduction and Business Overview

7.4.3 Dimension Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Dimension Therapeutics Gene Therapy Products Product Offerings

7.4.5 Dimension Therapeutics Recent Development

7.5 Avalanche Bio

7.5.1 Avalanche Bio Company Information

7.5.2 Avalanche Bio Introduction and Business Overview

7.5.3 Avalanche Bio Gene Therapy Products Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Avalanche Bio Gene Therapy Products Product Offerings

7.5.5 Avalanche Bio Recent Development

7.6 Celladon

7.6.1 Celladon Company Information

7.6.2 Celladon Introduction and Business Overview

7.6.3 Celladon Gene Therapy Products Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Celladon Gene Therapy Products Product Offerings

7.6.5 Celladon Recent Development

7.7 Vical Inc.

7.7.1 Vical Inc. Company Information

7.7.2 Vical Inc. Introduction and Business Overview

7.7.3 Vical Inc. Gene Therapy Products Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Vical Inc. Gene Therapy Products Product Offerings

7.7.5 Vical Inc. Recent Development

7.8 Advantagene

7.8.1 Advantagene Company Information

7.8.2 Advantagene Introduction and Business Overview

7.8.3 Advantagene Gene Therapy Products Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Advantagene Gene Therapy Products Product Offerings

7.8.5 Advantagene Recent Development

8 Industry Chain Analysis

8.1 Gene Therapy Products Industrial Chain

8.2 Gene Therapy Products Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Gene Therapy Products Sales Model

8.5.2 Sales Channel

8.5.3 Gene Therapy Products Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Bluebird bio

Sangamo

Spark Therapeutics

Dimension Therapeutics

List of Tables

Table 1. Gene Therapy Products Market Trends

Table 2. Gene Therapy Products Market Drivers & Opportunity

Table 3. Gene Therapy Products Market Challenges

Table 4. Gene Therapy Products Market Restraints

Table 5. Global Gene Therapy Products Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Gene Therapy Products Revenue Market Share by Company (2019-2024)

Table 7. Global Gene Therapy Products Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Gene Therapy Products Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Gene Therapy Products Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Gene Therapy Products Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Gene Therapy Products Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Gene Therapy Products

Table 13. Global Gene Therapy Products Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Products as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Gene Therapy Products Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Gene Therapy Products Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Gene Therapy Products Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Gene Therapy Products Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Gene Therapy Products Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Gene Therapy Products Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Gene Therapy Products Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Gene Therapy Products Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Gene Therapy Products Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Gene Therapy Products Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Gene Therapy Products Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Gene Therapy Products Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Gene Therapy Products Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Gene Therapy Products Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Gene Therapy Products Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Gene Therapy Products Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Gene Therapy Products Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Gene Therapy Products Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Gene Therapy Products Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Gene Therapy Products Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Gene Therapy Products Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Gene Therapy Products Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Gene Therapy Products Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Gene Therapy Products Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Gene Therapy Products Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Gene Therapy Products Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Gene Therapy Products Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Gene Therapy Products Sales Value by Region (2019-2024) & (%)

Table 44. Global Gene Therapy Products Sales Value by Region (2025-2030) & (%)

Table 45. Global Gene Therapy Products Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Gene Therapy Products Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Gene Therapy Products Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Gene Therapy Products Sales Volume by Region (2019-2024) & (%)

Table 49. Global Gene Therapy Products Sales Volume by Region (2025-2030) & (%)

Table 50. Global Gene Therapy Products Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Gene Therapy Products Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Gene Therapy Products Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Gene Therapy Products Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Gene Therapy Products Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Gene Therapy Products Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Gene Therapy Products Sales Volume, (2025-2030) & (K Units)

Table 57. Bluebird Bio Company Information

Table 58. Bluebird Bio Introduction and Business Overview

Table 59. Bluebird Bio Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Bluebird Bio Gene Therapy Products Product Offerings

Table 61. Bluebird Bio Recent Development

Table 62. Sangamo Company Information

Table 63. Sangamo Introduction and Business Overview

Table 64. Sangamo Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Sangamo Gene Therapy Products Product Offerings

Table 66. Sangamo Recent Development

Table 67. Spark Therapeutics Company Information

Table 68. Spark Therapeutics Introduction and Business Overview

Table 69. Spark Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Spark Therapeutics Gene Therapy Products Product Offerings

Table 71. Spark Therapeutics Recent Development

Table 72. Dimension Therapeutics Company Information

Table 73. Dimension Therapeutics Introduction and Business Overview

Table 74. Dimension Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Dimension Therapeutics Gene Therapy Products Product Offerings

Table 76. Dimension Therapeutics Recent Development

Table 77. Avalanche Bio Company Information

Table 78. Avalanche Bio Introduction and Business Overview

Table 79. Avalanche Bio Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Avalanche Bio Gene Therapy Products Product Offerings

Table 81. Avalanche Bio Recent Development

Table 82. Celladon Company Information

Table 83. Celladon Introduction and Business Overview

Table 84. Celladon Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Celladon Gene Therapy Products Product Offerings

Table 86. Celladon Recent Development

Table 87. Vical Inc. Company Information

Table 88. Vical Inc. Introduction and Business Overview

Table 89. Vical Inc. Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Vical Inc. Gene Therapy Products Product Offerings

Table 91. Vical Inc. Recent Development

Table 92. Advantagene Company Information

Table 93. Advantagene Introduction and Business Overview

Table 94. Advantagene Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Advantagene Gene Therapy Products Product Offerings

Table 96. Advantagene Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Gene Therapy Products Downstream Customers

Table 100. Gene Therapy Products Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Gene Therapy Products Product Picture

Figure 2. Global Gene Therapy Products Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Gene Therapy Products Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Gene Therapy Products Sales Volume (2019-2030) & (K Units)

Figure 5. Global Gene Therapy Products Sales Price (2019-2030) & (US$/Unit)

Figure 6. Gene Therapy Products Report Years Considered

Figure 7. Global Gene Therapy Products Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Gene Therapy Products Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Gene Therapy Products Revenue in 2023

Figure 10. Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Ex vivo Picture

Figure 12. In Vivo Picture

Figure 13. Global Gene Therapy Products Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Gene Therapy Products Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Gene Therapy Products Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Gene Therapy Products Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Gene Therapy Products Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Cancer

Figure 19. Product Picture of Monogenic

Figure 20. Product Picture of Infectious disease

Figure 21. Product Picture of Cardiovascular disease

Figure 22. Product Picture of Other

Figure 23. Global Gene Therapy Products Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Gene Therapy Products Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Gene Therapy Products Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Gene Therapy Products Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Gene Therapy Products Price by Application (2019-2030) & (US$/Unit)

Figure 28. North America Gene Therapy Products Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Gene Therapy Products Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Gene Therapy Products Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Gene Therapy Products Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Gene Therapy Products Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Gene Therapy Products Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Gene Therapy Products Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Gene Therapy Products Sales Volume (%), (2019-2030)

Figure 40. United States Gene Therapy Products Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Gene Therapy Products Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Gene Therapy Products Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Gene Therapy Products Sales Value by Application (%), 2023 VS 2030

Figure 46. China Gene Therapy Products Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

Figure 48. China Gene Therapy Products Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Gene Therapy Products Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Gene Therapy Products Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Gene Therapy Products Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Gene Therapy Products Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Gene Therapy Products Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Gene Therapy Products Sales Value by Application (%), 2023 VS 2030

Figure 58. India Gene Therapy Products Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Gene Therapy Products Sales Value by Type (%), 2023 VS 2030

Figure 60. India Gene Therapy Products Sales Value by Application (%), 2023 VS 2030

Figure 61. Gene Therapy Products Industrial Chain

Figure 62. Gene Therapy Products Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Feed Additives Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18N4245

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Isoniazid APIs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8M19246

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Aseptic Sampling System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33F5872

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Centrifugal Pump for Pharmaceutical Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18T10008

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions